iHuman Inc. (IH)
| Previous close | 1.7300 |
| Open | 1.8100 |
| Bid | 1.7400 x 1100 |
| Ask | 1.7500 x 1000 |
| Day's range | 1.7400 - 1.8100 |
| 52-week range | 1.6800 - 4.0000 |
| Volume | |
| Avg. volume | 25,560 |
| Market cap | 91.769M |
| Beta (5Y monthly) | 0.38 |
| PE ratio (TTM) | 3.78 |
| EPS (TTM) | 0.4600 |
| Earnings date | 19 Jun 2024 - 24 Jun 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 27 Mar 2024 |
| 1y target est | N/A |
PR NewswireiHuman Inc. Files 2023 Annual Report on Form 20-F
iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced that it filed its annual report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission on April 25, 2024. The annual report on Form 20-F is available on the Company's investor relations website at https://ir.ihuman.com/. iHuman will provide a hard copy of its annual report on Form 20-F containing complete a
Simply Wall St.iHuman Full Year 2023 Earnings: EPS: CN¥3.43 (vs CN¥2.06 in FY 2022)
iHuman ( NYSE:IH ) Full Year 2023 Results Key Financial Results Revenue: CN¥1.02b (up 3.3% from FY 2022). Net income...
- PR Newswire
iHuman Inc. Announces Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results
iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023.
